KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Outstanding
Ratios

Teva Pharmaceutical Industries (TEVA) Shares Outstanding (2016 - 2025)

Historic Shares Outstanding for Teva Pharmaceutical Industries (TEVA) over the last 17 years, with Q3 2025 value amounting to $1.3 billion.

  • Teva Pharmaceutical Industries' Shares Outstanding rose 104.84% to $1.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 billion, marking a year-over-year increase of 104.84%. This contributed to the annual value of $1.2 billion for FY2024, which is 333.33% up from last year.
  • Teva Pharmaceutical Industries' Shares Outstanding amounted to $1.3 billion in Q3 2025, which was up 104.84% from $1.3 billion recorded in Q2 2025.
  • Teva Pharmaceutical Industries' Shares Outstanding's 5-year high stood at $1.3 billion during Q1 2025, with a 5-year trough of $1.2 billion in Q4 2024.
  • Moreover, its 5-year median value for Shares Outstanding was $1.2 billion (2023), whereas its average is $1.2 billion.
  • In the last 5 years, Teva Pharmaceutical Industries' Shares Outstanding crashed by 220.05% in 2024 and then skyrocketed by 121.16% in 2025.
  • Teva Pharmaceutical Industries' Shares Outstanding (Quarter) stood at $1.2 billion in 2021, then grew by 0.66% to $1.2 billion in 2022, then increased by 0.82% to $1.2 billion in 2023, then dropped by 2.2% to $1.2 billion in 2024, then grew by 4.42% to $1.3 billion in 2025.
  • Its Shares Outstanding was $1.3 billion in Q3 2025, compared to $1.3 billion in Q2 2025 and $1.3 billion in Q1 2025.